Clinical Application and Progress of the Fractional Photothermolysis in Dermatology

LI Rui-lian,WANG Mei,WANG Yong-xian
2011-01-01
Abstract:The novel concept of non-ablative fractional photothermolysis was introduced to the market in 2004 as an answer to the need of effective,yet low risk,resurfacing techniques.Unlike conventional ablative and non-ablative lasers,fractional ablative and non-ablative photothermolysis focus on a fraction of the skin,while other a maximum of 95% of the skin uninvolved.The undamaged surrounding tissue remained a reservoir of viable tissue,permitting rapid epidermal repair.In 2006 non-ablative fractional photothermolysis was approved by the USA Food and Drug Administration(FDA) for the treatment of pigmented lesions,periorbital rhytides,skin resurfacing,melasma and soft tissue coagulation,acne and surgical scars,and actinic keratoses.However,its off-label use was extended clearly.In 2007 the concept was further developed,and ablative fractional photothermolysis was introduced by using an erbium yttrium aluminium garnet(Er:YAG) or carbon dioxide laser.These devices were confirmed by FDA to treat wrinkles,rhytides,furrows,fine lines,textural irregularities,pigmented lesions and vascular dyschromia.In this review we discussed the two concepts of Fractional photother-molysis,their technical clinical indications detailly.
What problem does this paper attempt to address?